BOPPY-based novel fluorescent dopamine D2 and D3 receptor ligands

被引:9
|
作者
Elek, Milica [1 ]
Dubiel, Mariam [1 ]
Mayer, Laura [2 ]
Zivkovic, Aleksandra [1 ]
Mueller, Thomas J. J. [2 ]
Stark, Holger [1 ]
机构
[1] Heinrich Heine Univ Dusseldorf, Inst Pharmaceut & Med Chem, Univ Str 1, D-40225 Dusseldorf, Germany
[2] Heinrich Heine Univ Dusseldorf, Inst Organ Chem, Univ Str 1, D-40225 Dusseldorf, Germany
关键词
Dopamine; BOPPY; D2R; D3R; Fluorescence; Ligands; HIGHLY FLUORESCENT; HIGH-AFFINITY; BODIPY DYES; D3; SCHIZOPHRENIA; BIOLOGY; BINDING; PROBES; TARGET;
D O I
10.1016/j.bmcl.2022.128573
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Dopamine is one of the crucial neurotransmitters in the human brain. Its out-of-range concentration can lead to various neurological diseases with special interest for dopamine D-2 and D-3 receptor subtypes. Although BODIPY is a highly versatile structural moiety for fluorescence labeling, we have looked out for structurally related pyridine-based moieties. We used BOPPY labelling of well-described D2R/D3R pharmacophores to obtain ligands with moderate to low nanomolar binding affinities as well as low to excellent quantum yields for bright fluorescence ligands. To best of our knowledge, this is the first report on the application of BOPPY fluorophores to GPCR ligands. This approach offers a general applicable way for fluorescence labelling via primary aliphatic amine elements.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Pramipexole Upregulates Dopamine Receptor D2 and D3 Expression in Rat Striatum
    Tokunaga, Naohito
    Choudhury, Mohammed -Emamussalehin
    Nishikawa, Noriko
    Nagai, Masahiro
    Tujii, Tomoaki
    Iwaki, Hirotaka
    Kaneta, Mika
    Nomoto, Masahiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 120 (02) : 133 - 137
  • [42] Association of genetic ancestry with striatal dopamine D2/D3 receptor availability
    C E Wiers
    P C Towb
    C A Hodgkinson
    P-H Shen
    C Freeman
    G Miller
    E Lindgren
    E Shokri-Kojori
    Ş B Demiral
    S W Kim
    D Tomasi
    H Sun
    G-J Wang
    D Goldman
    N D Volkow
    Molecular Psychiatry, 2018, 23 : 1711 - 1716
  • [43] Improving selectivity of dopamine D3 receptor ligands
    Capet, Marc
    Calmels, Thierry
    Levoin, Nicolas
    Danvy, Denis
    Berrebi-Bertrand, Isabelle
    Stark, Holger
    Schwartz, Jean-Charles
    Lecomte, Jeanne-Marie
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (03) : 885 - 888
  • [44] In Vitro and In Vivo Identification of Novel Positive Allosteric Modulators of the Human Dopamine D2 and D3 Receptor
    Wood, Martyn
    Ates, Ali
    Andre, Veronique Marie
    Michel, Anne
    Barnaby, Robert
    Gillard, Michel
    MOLECULAR PHARMACOLOGY, 2016, 89 (02) : 303 - 312
  • [45] SH3 ligands in the dopamine D3 receptor
    Oldenhof, J
    Ray, A
    Vickery, R
    Van Tol, HHM
    CELLULAR SIGNALLING, 2001, 13 (06) : 411 - 416
  • [46] Dopamine D3/D2 Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective Disorders
    Gogarnoiu, Emma S.
    Vogt, Caleb D.
    Sanchez, Julie
    Bonifazi, Alessandro
    Saab, Elizabeth
    Shaik, Anver Basha
    Soler-Cedeno, Omar
    Bi, Guo-Hua
    Klein, Benjamin
    Xi, Zheng-Xiong
    Lane, J. Robert
    Newman, Amy Hauck
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (03) : 1809 - 1834
  • [47] The Impact of Selective Dopamine D2, D3 and D4 Ligands on the Rat Gambling Task
    Di Ciano, Patricia
    Pushparaj, Abhiram
    Kim, Aaron
    Hatch, Jessica
    Masood, Talal
    Ramzi, Abby
    Khaled, Maram A. T. M.
    Boileau, Isabelle
    Winstanley, Catherine A.
    Le Foll, Bernard
    PLOS ONE, 2015, 10 (09):
  • [48] Locomotor activity induced by MK-801 is enhanced in dopamine D3 receptor knockout mice but suppression by dopamine D3/D2 antagonists does not occur through the dopamine D3 receptor
    Yarkov, Alex V.
    Der, Terry C.
    Joyce, Jeffrey N.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 627 (1-3) : 167 - 172
  • [49] Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease
    Ryoo, HL
    Pierrotti, D
    Joyce, JN
    MOVEMENT DISORDERS, 1998, 13 (05) : 788 - 797
  • [50] MOLECULAR CHARACTERIZATION OF THE D2, D3, D4 DOPAMINE-RECEPTOR FAMILY
    CIVELLI, O
    NEUROPSYCHOPHARMACOLOGY, 1993, 9 (02) : S35 - S35